BioWorld

Aug. 16, 2002

ImClone Files $7M Suit Against Sam Waksal, Reports Earnings

ImClone Systems Inc. filed a lawsuit against its founder and former CEO, Sam Waksal, claiming he destroyed documents possibly relevant to a government investigation of the company's business practices. (BioWorld Today) Read More

Genaera Reduces Staff To Focus On Select Products

Texas Soil Yields Molecule Of Unprecedented Power; Ecopia, Academics Domesticating It

Ribozyme Expands Focus, Cuts Staff By 30 Employees

MedImmune Enters Deals With Biosite, ViroNovative

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 8, 2026.

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

In the clinic for July 6, 2026

BioWorld

Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.